JP2014505733A5 - - Google Patents

Download PDF

Info

Publication number
JP2014505733A5
JP2014505733A5 JP2013554551A JP2013554551A JP2014505733A5 JP 2014505733 A5 JP2014505733 A5 JP 2014505733A5 JP 2013554551 A JP2013554551 A JP 2013554551A JP 2013554551 A JP2013554551 A JP 2013554551A JP 2014505733 A5 JP2014505733 A5 JP 2014505733A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
oxymetazoline
composition according
amount
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013554551A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014505733A (ja
JP6225030B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/025068 external-priority patent/WO2012112566A1/en
Publication of JP2014505733A publication Critical patent/JP2014505733A/ja
Publication of JP2014505733A5 publication Critical patent/JP2014505733A5/ja
Application granted granted Critical
Publication of JP6225030B2 publication Critical patent/JP6225030B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013554551A 2011-02-15 2012-02-14 酒さの症状を治療するためのオキシメタゾリンの薬学的クリーム組成物 Active JP6225030B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161443210P 2011-02-15 2011-02-15
US61/443,210 2011-02-15
PCT/US2012/025068 WO2012112566A1 (en) 2011-02-15 2012-02-14 Pharmaceutical cream compositions of oxymetazoline for treating symptoms of rosacea

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017002106A Division JP6389534B2 (ja) 2011-02-15 2017-01-10 酒さの症状を治療するためのオキシメタゾリンの薬学的クリーム組成物

Publications (3)

Publication Number Publication Date
JP2014505733A JP2014505733A (ja) 2014-03-06
JP2014505733A5 true JP2014505733A5 (enExample) 2015-04-09
JP6225030B2 JP6225030B2 (ja) 2017-11-01

Family

ID=45757218

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2013554551A Active JP6225030B2 (ja) 2011-02-15 2012-02-14 酒さの症状を治療するためのオキシメタゾリンの薬学的クリーム組成物
JP2017002106A Active JP6389534B2 (ja) 2011-02-15 2017-01-10 酒さの症状を治療するためのオキシメタゾリンの薬学的クリーム組成物
JP2018153450A Abandoned JP2018193399A (ja) 2011-02-15 2018-08-17 酒さの症状を治療するためのオキシメタゾリンの薬学的クリーム組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2017002106A Active JP6389534B2 (ja) 2011-02-15 2017-01-10 酒さの症状を治療するためのオキシメタゾリンの薬学的クリーム組成物
JP2018153450A Abandoned JP2018193399A (ja) 2011-02-15 2018-08-17 酒さの症状を治療するためのオキシメタゾリンの薬学的クリーム組成物

Country Status (11)

Country Link
US (4) US20120208858A1 (enExample)
EP (2) EP2675449B1 (enExample)
JP (3) JP6225030B2 (enExample)
KR (2) KR102058756B1 (enExample)
CN (2) CN107007546A (enExample)
AU (3) AU2012217858A1 (enExample)
BR (1) BR112013020770A2 (enExample)
CA (1) CA2827373C (enExample)
ES (1) ES2742273T3 (enExample)
RU (1) RU2648439C2 (enExample)
WO (1) WO2012112566A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
MX2007009796A (es) 2007-08-14 2009-02-25 Cell Therapy And Technology S Gel conteniendo pirfenidona.
RU2648439C2 (ru) 2011-02-15 2018-03-26 Аллерган, Инк. Фармацевтическая композиция в виде крема, содержащая оксиметазолин, для лечения симптомов розацеа
US20120225918A1 (en) * 2011-03-03 2012-09-06 Voom, Llc Compositions and Methods for Non-Surgical Treatment of Ptosis
MX2011007675A (es) 2011-07-19 2012-07-11 Cell Therapy And Technology S A De C V Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas.
WO2013020021A1 (en) * 2011-08-04 2013-02-07 Omeros Corporation Stable anti-inflammatory solutions for injection
PH12014500636B1 (en) 2011-09-20 2019-11-20 Allergan Inc Compositions and methods for treating presbyopia, mild hyperopia, and irregular astigmatism
MX346763B (es) 2012-03-28 2017-03-31 Cell Therapy And Tech S A De C V Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acné.
MX356551B (es) 2012-08-23 2018-06-04 Grupo Medifarma S A De C V Star Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné.
FR3000395A1 (fr) * 2012-12-31 2014-07-04 Galderma Res & Dev Combinaison de laropiprant et d'oxymetazoline pour le traitement de la rosacee
WO2014121027A1 (en) 2013-02-01 2014-08-07 Oculars Pharma, Llc Aqueous ophthalmic solutions of phentolamine and medical uses thereof
US9089560B2 (en) 2013-02-01 2015-07-28 Ocularis Pharma, Llc Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance
US20160243238A1 (en) * 2013-10-28 2016-08-25 Cipher Pharmaceuticals Compositions for Dermatological Use
CA2947603A1 (en) * 2014-05-01 2015-11-05 Anterios, Inc. Demonstrable efficacy across or within patient populations
WO2015191917A1 (en) 2014-06-11 2015-12-17 Allergan, Inc. Stabilized oxymetazoline formulations and their uses
AU2016323967A1 (en) * 2015-09-17 2018-03-22 June Jacobs Laboratories, Llc Compositions and methods for the treatment and prevention of radiation dermatitis
US10744135B2 (en) * 2016-06-28 2020-08-18 Doris Maria HEXSEL Use of an active substance in the treatment of melasma
BR112019010131A2 (pt) 2016-11-21 2019-10-08 Eirion Therapeutics, Inc. entrega transdérmica de agentes grandes
EA202090763A1 (ru) * 2017-11-15 2020-08-03 Борис Славинович ФАРБЕР Фармацевтическая композиция для стимуляции деления стволовых клеток и подавления вирулентности бактерий
MX368750B (es) * 2018-08-31 2019-10-15 Cell Therapy And Tech S A De C V Composiciones farmaceuticas semisolidas de base oleosa conteniendo pirfenidona para su aplicacion en la reparacion tisular.
WO2020081562A1 (en) 2018-10-15 2020-04-23 Ocuphire Pharma, Inc. Methods and compositions for treatment of glaucoma and related conditions
MX2021004708A (es) 2018-10-26 2021-11-03 Ocuphire Pharma Inc Metodos y composiciones para tratamiento de presbicia, midriasis y otros trastornos oculares.
JP2022509174A (ja) * 2018-11-26 2022-01-20 セリックス バイオ プライヴェート リミテッド 皮膚疾患及び眼疾患の処置のための眼科用組成物及び方法
CA3133733A1 (en) * 2019-04-30 2020-11-05 Xin-Yuan Fu Compounds for treating inflammation induced autoimmune skin diseases and uses thereof
CN115368310B (zh) 2021-05-18 2025-06-27 奥库菲尔医药公司 合成甲磺酸酚妥拉明的方法
KR102633256B1 (ko) * 2021-10-08 2024-02-05 (주)우리스마트바이오 참당귀 추출물을 이용한 피부개선용 화장품 조성물, 이를 포함한 피부개선용 화장품 및 피부개선용 화장품 제조방법
KR20240159565A (ko) * 2022-01-05 2024-11-05 아시메트릭 테라퓨틱스, 엘엘씨 피부 증식성 장애 및 다른 피부 병태 치료를 위한 방법 및 조성물
US20240423959A1 (en) * 2022-06-21 2024-12-26 Jjr&D, Llc Topical benzimidazole formulations and methods for use in treating inflammatory dermatoses

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147275A (en) 1964-09-01 Nh-cha
US8093293B2 (en) * 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US6433024B1 (en) 2000-05-08 2002-08-13 Karl F. Popp Topical anti-acne composition
JP2004506947A (ja) 2000-08-16 2004-03-04 ドルビー・ラボラトリーズ・ライセンシング・コーポレーション 補足情報に応答するオーディオ又はビデオ知覚符号化システムのパラメータ変調
US6479060B1 (en) * 2001-09-04 2002-11-12 Healthpoint, Ltd. Elegant hydrogenated castor oil ointments
US6824786B2 (en) 2001-11-27 2004-11-30 Ruey J. Yu Compositions comprising phenyl-glycine derivatives
US6573301B1 (en) 2002-04-23 2003-06-03 Bradley Pharmaceuticals, Inc. Carbamide peroxide compositions for the treatment of dermatological disorders and methods for their use
US7439241B2 (en) * 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
US7812049B2 (en) * 2004-01-22 2010-10-12 Vicept Therapeutics, Inc. Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists
NZ552325A (en) * 2004-05-25 2010-11-26 Sansrosa Pharmaceutical Dev Inc The use of alpha 2 andrenoceptor agonists such as brimonidine for treating inflammatory skin disorders
CN101166535A (zh) 2005-03-15 2008-04-23 坎皮纳荷兰控股有限责任公司 乳蛋白的皮肤病学应用
CA2600384C (en) * 2005-03-30 2016-08-30 Revance Therapeutics, Inc. Compositions and methods for treating acne
JP5129130B2 (ja) 2005-06-29 2013-01-23 ディーエスエム アイピー アセッツ ビー．ブイ． イソフラボンのナノ粒子を含む局所組成物
CA2644311C (en) * 2006-03-01 2012-07-10 Tristrata, Inc. Composition and method for topical treatment of tar-responsive dermatological disorders
US20080031979A1 (en) * 2006-08-04 2008-02-07 Claude Saliou Use of extracts for the treatment of viral disorders
RU2310439C1 (ru) * 2006-10-05 2007-11-20 Закрытое акционерное общество Фармацевтическое научно-производственное предприятие "Ретиноиды" (ЗАО "Ретиноиды") Мазевая акарицидная композиция и способ лечения демодекоза и сопутствующих ему заболеваний
US9511016B2 (en) * 2007-06-12 2016-12-06 Epicentrx, Inc. Topical composition for treating pain
US20090061020A1 (en) 2007-08-31 2009-03-05 Theobald Klaus P Brimonidine Compositions for Treating Erythema
ES2709120T3 (es) 2007-11-16 2019-04-15 Aclaris Therapeutics Inc Composiciones y métodos para tratar la púrpura
US20090130029A1 (en) * 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
MX2012004890A (es) 2009-10-26 2012-09-28 Galderma Pharma Sa Metodos para tratar o prevenir eritema agudo.
US20120082625A1 (en) 2010-09-28 2012-04-05 Michael Graeber Combination treatment for rosacea
US8883838B2 (en) 2010-12-03 2014-11-11 Allergan, Inc. Pharmaceutical cream compositions and methods of use
RU2648439C2 (ru) 2011-02-15 2018-03-26 Аллерган, Инк. Фармацевтическая композиция в виде крема, содержащая оксиметазолин, для лечения симптомов розацеа
US20130079379A1 (en) 2011-07-14 2013-03-28 Allergan, Inc. Gel compositions of oxymetazoline and methods of use

Similar Documents

Publication Publication Date Title
JP2014505733A5 (enExample)
JP2010222367A5 (enExample)
RU2013141845A (ru) Фармацевтическая композиция в виде крема, содержащая оксиметазолин, для лечения симптомов розацеа
MX361590B (es) Suministro topico de composiciones para la piel que tienen ph bajo.
PH12017502092A1 (en) Topical pharmaceutical compositions
BR112015029491A2 (pt) derivados de imidazopirrolidinona e seu uso no tratamento de doença
BR112015029512A2 (pt) derivados de pirazolopirrolidina e seu uso no tratamento de doenças
HRP20191919T1 (hr) Donori nitroksila sa poboljšanim terapijskim indeksom
UA109991C2 (xx) Карбаматні сполуки, їх отримання і застосування
PH12013500215B1 (en) Corticosteroids for the treatment of joint pain
CO2019008053A2 (es) Agente terapéutico para enfermedades del hígado
ME02841B (me) Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze
MX362485B (es) Nuevos inhibidores de rock.
MX2013003635A (es) Compuestos de n-heteroarilo.
JP2017537936A5 (enExample)
WO2017022962A8 (ko) Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물
NZ720328A (en) Pyranochromenyl phenol derivative, and pharmaceutical composition for treating metabolic syndrome or inflammatory disease
MX2024000828A (es) Formulaciones de parasiticida de isoxazolina y metodos para el tratamiento de la blefaritis.
WO2017182873A3 (en) Peptide-oligourea foldamer compounds and methods of their use
JP2014520892A5 (enExample)
JP2016538288A5 (enExample)
MX2014014818A (es) Composicion farmaceutica para el tratamiento de enfermedades inflamatorias de la piel.
EA201591653A1 (ru) Композиции для лечения глазных расстройств с применением дипиридамола
WO2019004788A3 (ko) 브라우쏘칼콘 a를 유효성분으로 포함하는 염증성 장질환 예방 또는 치료용 약학 조성물
JP2014162761A5 (enExample)